01952.HK
Everest Medicines Limited
HKSE · Healthcare · Biotechnology · CN
HKD 31.98
−1.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 27.95x
- P/E 2027E
- 24.36x
- P/E 2028E
- 10.89x
- P/S forward
- 4.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.76x
- Price / sales
- 3.83x
- Price / cash flow
- -50.23x
Enterprise value
- Enterprise value
- HKD 10.7B
- EV / sales
- 3.81x
- EV / EBITDA
- 236.38x
- EV / EBIT
- -71.81x
- Market cap
- HKD 10.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026